These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6372264)

  • 1. Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs.
    Kripalani KJ; Dean AV; Migdalof BH
    Xenobiotica; 1983 Dec; 13(12):701-5. PubMed ID: 6372264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.
    Park BK; Grabowski PS; Yeung JH; Breckenridge AM
    Biochem Pharmacol; 1982 May; 31(9):1755-60. PubMed ID: 7049181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-protein conjugates--IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat.
    Yeung JH; Breckenridge AM; Park BK
    Biochem Pharmacol; 1983 Sep; 32(17):2467-72. PubMed ID: 6351864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril: pharmacology, metabolism and disposition.
    Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
    Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
    Matsumoto K; Miyazaki H; Fujii T; Yoshida K; Amejima H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):40-6. PubMed ID: 3513776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
    Wood SG; John BA; Chasseaud LF; Johnstone I; Biggs SR; Hawkins DR; Priego JG; Darragh A; Lambe RF
    Xenobiotica; 1983 Dec; 13(12):731-42. PubMed ID: 6144210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans.
    Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA
    Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of captopril in dogs and monkeys.
    Singhvi SM; Peterson AE; Ross JJ; Shaw JM; Keim GR; Migdalof BH
    J Pharm Sci; 1981 Oct; 70(10):1108-12. PubMed ID: 7028947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on the metabolic pathway of SQ 14225 (Captopril) and mechanism of mixed disulfide formation.
    Komai T; Ikeda T; Kawai K; Kameyama E; Shindo H
    J Pharmacobiodyn; 1981 Sep; 4(9):677-84. PubMed ID: 7038090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug protein conjugates--VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates.
    Yeung JH; Breckenridge AM; Park BK
    Biochem Pharmacol; 1983 Dec; 32(23):3619-25. PubMed ID: 6360177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration.
    Heald AF; Ita CE; Singhvi SM; Migdalof BH
    Xenobiotica; 1985 Jan; 15(1):51-6. PubMed ID: 3885586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans.
    Wong KK; Lan S; Migdalof BH
    Biochem Pharmacol; 1981 Oct; 30(19):2643-50. PubMed ID: 7028042
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.
    Breda M; Benedetti MS; Battaglia R; Castelli MG; Poggesi I; Spinelli R; Hackett AM; Dostert P
    Pharmacol Res; 2000 Feb; 41(2):239-48. PubMed ID: 10623492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat.
    Drummer OH; Jarrott B
    Biochem Pharmacol; 1984 Nov; 33(22):3567-71. PubMed ID: 6095854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.